51744-55-9
英文名称
15H-9,12-Imino-21,2-metheno-4,7:17,14-dinitrilopyrano[4,3-b]azacyclononadecine-16-propanoic acid, 10-ethenyl-5-ethyl-1,16,18,20-tetrahydro-6,11,15,22-tetramethyl-18,20-dioxo-, methyl ester, (15S,16S)-
CAS
51744-55-9
分子式
C34H34N4O5
分子量
578.67
MOL 文件
51744-55-9.mol
51744-55-9 结构式
基本信息
英文别名
Purpurin 18 methyl ester15H-9,12-Imino-21,2-metheno-4,7:17,14-dinitrilopyrano[4,3-b]azacyclononadecine-16-propanoic acid, 10-ethenyl-5-ethyl-1,16,18,20-tetrahydro-6,11,15,22-tetramethyl-18,20-dioxo-, methyl ester, (15S,16S)-
常见问题列表
生物活性
Purpurin 18 methyl ester,叶绿素 a 的衍生物,是一种可用于光动力疗法 (PDT) 的光敏剂。Purpurin 18 methyl ester 具有光动力学活性,可诱导癌细胞死亡。体外研究
Purpurin 18 methyl ester (1-5 μg/mL; 24 h) has no cytotoxicity in dark in HepG-2 cells.
Purpurin 18 methyl ester (1-5 μg/mL; 24 h) decreases the viability of HepG-2 cells in a concentration-dependent manner with irradiation for 10 min.
Purpurin 18 methyl ester (0-24 h) is released from GO- Purpurin 18 methyl ester (Pu18) composite, with rates of 47%, 22% and 30% in weak acidic condition (pH 5.6), neutral environment (pH 7.4) and weak alkali condition (pH 8.9) for 24 h, respectively.